GENWORTH FINANCIAL INC quarterly report, Q3 FY2023

Genworth Financial, Inc. — 2023 Third-Quarter 10-Q

Reporting period: Quarter and nine months ended September 30, 2023; filed November 9, 2023. Amounts below are in U.S. dollars; financial statement amounts are in millions unless stated otherwise. Genworth reports Enact (mortgage insurance), Long-Term Care Insurance, Life and Annuities, and Corporate and Other. Prior periods were re-presented for the revised segment structure and adjusted for adoption of LDTI.

Key financial results

MetricThird quarter 2023Third quarter 2022Nine months 2023Nine months 2022
Total revenue$1,831$1,848$5,577$5,628
Income from continuing operations before tax$90$220$520$836
Net income available to Genworth common stockholders$29$136$288$535
Adjusted operating income available to common stockholders (non-GAAP)$42$158$271$480
Diluted earnings per share$0.06$0.27$0.60$1.04
Net cash from operating activitiesNot provided for quarterNot provided for quarter$450$645

Quarterly benefits and expenses rose to $1,741 from $1,628; nine-month expenses were $5,057 versus $4,792. Nine-month net investment income was $2,373 versus $2,359, while net investment losses were $15 versus a $3 gain. The filing does not provide a consolidated operating-margin measure.

At September 30, total assets were $85,466, total liabilities $76,588, and total equity $8,878. Cash, cash equivalents and restricted cash were $1,993, compared with $1,799 at December 31, 2022. Consolidated long-term borrowings were $1,602; Genworth Holdings separately reported $876 of principal outstanding and $232 of unrestricted cash, with no debt maturities until June 2034.

Material changes and segment performance

  • Profitability declined: Third-quarter common-stockholder net income fell 79% year over year; nine-month income fell 46%. Adjusted operating income declined 73% for the quarter and 44% year to date.
  • Long-Term Care Insurance: Adjusted operating loss was $71 for the quarter versus $26 income, and $91 loss for nine months versus $116 income. The nine-month liability remeasurement loss was $133, compared with a $62 gain in 2022. Management attributed the deterioration principally to settlement timing, higher claims, lower terminations, and less favorable rate-action assumption updates.
  • Enact: Adjusted operating income was $134 for the quarter and $423 year to date, down 14% and 8%, respectively. New insurance written fell 4% in the quarter and 17% year to date, mainly because elevated mortgage rates reduced originations. Primary insurance in-force increased 8% year over year to $262.0 billion; the quarter-end PMIERs sufficiency ratio was 162%, or $2.017 billion above requirements.
  • Life and Annuities: Adjusted operating loss narrowed to $3 for the quarter from $6 and to $5 year to date from $51. The products are generally runoff blocks, not actively marketed.
  • Cash flow and capital returns: Nine-month operating cash flow declined to $450 from $645. Investing activities provided $913 versus $452; financing activities used $1,170 versus $1,107. Genworth repurchased about 45.8 million shares for $264 during the nine months. At October 31, approximately $366 of repurchase authorization remained.

Outlook, risks and unusual items

  • Management reported approximately $227 of incremental annual premiums approved through the first nine months under its long-term-care rate-action plan. It estimates approved actions represent about $25 billion of cumulative economic benefit on a net-present-value basis, against an estimated total need of $30.3 billion. Approvals and implementation timing remain subject to regulators.
  • Management said fourth-quarter 2023 long-term-care assumption updates were still underway and could be negative in aggregate, with immediate earnings sensitivity in unprofitable cohorts. A third legal settlement covers policies representing about 35% of the block; management expects a net favorable economic effect over time, but results depend on policyholder elections.
  • Management expects higher long-term-care paid claims as insureds age and notes that LDTI contributes to quarterly GAAP volatility. Higher interest rates also affect insurance liabilities, investment values, and equity through discount-rate remeasurement.
  • Enact capital returns are an important source of holding-company liquidity. Genworth expected approximately $245 of Enact returns for full-year 2023; after quarter-end, Enact announced a $113 special dividend for the fourth quarter. These amounts are expectations or subsequent announcements, not cash received by September 30.
  • The MOVEit incident at third-party vendor PBI exposed and obtained personal information, including Social Security numbers, for approximately 2.5–2.7 million policyholders or other customers. Related class actions were consolidated; Genworth said it could not estimate reasonably possible losses. It did not believe the incident had materially disrupted operations.
  • Other material matters include the Scottish Re liquidation and a $69 reinsurance recoverable write-off, including an additional $33 credit-loss charge in the third quarter, offset by derecognition of ceded premiums. The filing also describes pending insurance, policyholder, ERISA and reinsurance disputes; loss estimates were not available for the identified matters.
  • Adoption of LDTI reduced stockholders’ equity by $13.7 billion at the January 1, 2021 transition date and materially changed reported insurance balances and earnings presentation. The company says adoption did not change cash flows or underlying economics. A material weakness in internal control related to LDTI settlement accounting was reported fully remediated during the quarter; management concluded disclosure controls were effective.

Important facts for investors to verify

  1. Whether the fourth-quarter long-term-care assumption review changes reserves or earnings, and how actual rate approvals and policyholder settlement elections compare with assumptions.
  2. Enact’s delinquency, cure, claims and new-business trends, especially given mortgage rates, home-price conditions and the concentration of growth in recent policy years.
  3. The amount and timing of Enact dividends and other capital returns actually received by Genworth Holdings, and the holding company’s liquidity after share repurchases and taxes.
  4. The scale and resolution of MOVEit-related claims and other litigation, since the filing provides no reasonably possible loss range for the identified legal matters.
  5. How much of the reported earnings and equity movement reflects operating performance versus LDTI remeasurement, interest-rate-driven unrealized investment losses, and non-GAAP exclusions.